We found that similar to LCLs, combined SCD1 and FADS2 inhibition arrested growth and hypersensitized EBV+ AIDS immunoblastic lymphoma IBL-1 cells to increased palmitate, pointing towards a unique targetable mechanism in EBV-associated lymphomas. This evidence concerns the gene FADS2 and lymphoma.